Skip to content

Recovery Act: Administrative Supplements to Currently Funded Projects – NIMH Areas for FY2010

American Recovery and Reinvestment Act of 2009 (Recovery Act)

NIH Announces the Availability of Recovery Act Funds for Administrative Supplements (NOT-OD-10-043 )

NIMH announces additional opportunities for investigators and U.S. institutions with active research grants to request 1 year of supplemental funding in FY2010 for the purpose of promoting job creation, economic development, and accelerating the pace and achievement of scientific research. NIMH has identified specific areas of interest in accordance with its goal of accelerating mental health research as described in the Institute’s Strategic Plan. Funding decisions related to HIV/AIDS will be based on the Trans-NIH Plan for HIV-Related Research  and funding decisions related to training will be based on the 2008 National Advisory Mental Health Council Workgroup report on research training (“Investing in the Future”).

Only administrative supplement requests that focus on one of the three topic areas listed below will be considered for funding. All supplement requests must be received by March 5, 2010 at 5pm (local time).

NIMH research areas to be considered for 1-year of supplemental funding with FY2010 Recovery Act funds are:

  1. Supplements to support sharing autism spectrum disorder data via the National Database for Autism Research

    Funds are available for administrative supplements to support activities associated with submitting autism related human subject research data to the National Database for Autism Research (NDAR, ). Established by the NIH, NDAR is a secure bioinformatics platform for scientific collaboration and data-sharing that enables the effective communication of detailed research data, tools, and supporting documentation across the research community. A central function of NDAR is to store and to link together genetic, phenotypic, image and other data derived from autism research projects.

    Administrative supplements will support data sharing activities, which include: generation of Global Unique Identifiers (GUIDs) for research subjects, data definition, and data validation. Investigators are expected to certify the quality of all data prior to submission to NDAR and to review their data for accuracy after submission. Investigators are urged to consult two tools as they develop their administrative supplement:

    1. NDAR Data Sharing Checklist ( ) – A list of critical steps in the data submission process, including informed consent language and GUID generation.
    2. NDAR Data Submission Planning Cost and Effort Model ( ) – A customizable Excel worksheet that includes tasks and hours for the Principal Investigator and Data Manager. This cost and effort model should be used in developing budget requests (with allowance for the requester’s specific circumstances).

    Please refer to the NDAR standards page at  for technical specifications, templates, and codebooks that can provide additional insight for submission planning.

    The NDAR Data Sharing Policy ( ) provides a two-tiered submission schedule that includes a timeline for descriptive data (e.g., clinical assessments, raw imaging data) and experimental data (e.g., outcomes measures, processed images). Submission of descriptive data is expected semi-annually (every January 15 and July 15); submission of all other experimental data is expected after the primary objectives of the grant have been met (the primary objectives of a grant will be determined in consultation with the investigator’s program officer prior to award).

    Questions regarding these supplements should be directed to the program officer for the grant to be supplemented; questions regarding NDAR should be directed to Dan Hall, NDAR Manager,

  2. Supplements to support specified opportunities within the Conte Center grant programs (to apply under this topic area, the PI must have an active Conte Center grant)

    1. Enhancing public outreach and dissemination: these supplements will support activities that enhance general public awareness of the importance and implications of Conte Center research for understanding the biology of mental disorders. Such efforts are also expected to enhance science literacy. Activities may include events in conjunction with local science museums, school systems, Brain Awareness Week, National DNA Day, etc. and/or activities with groups affiliated with the NIMH Outreach Partnership Program.
    2. Supplements to further support specific scientific areas: a) studies to elucidate sex differences throughout development and across multiple levels of analysis to understand their contribution to variation in cognitive, social, and emotional function as well as risk for mental disorders, b) studies to investigate neurodevelopmental mechanisms that relate to cognitive, social, and emotional function and dysfunction, and c) efforts to develop novel and innovative approaches to managing and analyzing complex data sets.
    3. Supplements to Conte Centers that focus in on one of the following aspects in studies of patients with mental disorders: a) analyses of extant data sets that address personalized medicine through pharmacogenomic or similar analyses of etiology, outcome, or side effects; b) secondary analyses that address mechanisms of pathophysiology and/or psychopathology that cut across traditional diagnostic categories (such as fear circuit activity or executive control); and c) secondary analyses of large data sets that integrate multiple levels of analysis.

    Questions regarding these supplements should be directed to the program officer for the Conte Center grant to be supplemented. Funding for this topic area is generally expected to be no more than 25% of the total cost of the parent grant (includes facilities and administration costs (F&A)).

  3. Supplements to support the area of pharmacogenomics and the predictors of specific adverse drug effects

    These supplements should further support work that seeks to identify genomic predictors of the occurrence of agranulocytosis in the use of clozapine for the treatment of individuals with schizophrenia.

    Questions regarding this topic area should be directed to Thomas Lehner, Ph.D., M.P.H., (301) 443-9869; Generally requests are expected to be no more that 25% of the total costs of the parent grant. That said, supplement requests cannot to exceed $2 million in total costs (includes F&A).

To be eligible for a FY2010 Recovery Act Administrative Supplement:

  • The parent grant must be active and the research proposed in the supplement must be able to be accomplished within the current competitive segment. No-cost extensions will not be granted to permit the submission of a supplement request.
  • Supplement requests cannot exceed 1 year or the time remaining on the parent grant, whichever is less.
  • Generally requests are expected to be no more that 25% of the total costs of the parent grant. That said, supplement requests cannot to exceed $2 million in total costs (includes F&A).
  • The proposed administrative supplement MUST be within the general scope of the peer-reviewed activities and aims approved for the parent grant.
  • Applications from foreign institutions are not permitted. Consistent with the goals of the Recovery Act to preserve and create jobs and promote economic recovery in the United States, applicant must be domestic (United States) institutions/organizations (i.e., located in the 50 states, territories and possessions of the United States, Commonwealth of Puerto Rico, Trust Territory of the Pacific Islands, or District of Columbia). In addition, domestic U.S. institutions planning to submit supplement requests that include foreign components should be aware that requested funding for any foreign components should not exceed 10% of the total requested direct costs or $25,000 per year (per subcontract/subaward or in aggregate for multiple subcontracts/subawards), whichever is less.


Administrative Supplement requests should be submitted electronically by the PI of the parent grant and the packet must include:

  1. Cover Letter – The cover letter must be signed by the authorized organizational representative and should indicate that you are requesting an Administrative Supplement in response to NOT-OD-09-056. The content of the letter should include the following information:

    • Project Director/Principal Investigator (PD/PI) name on the parent grant
    • Parent grant number and title
    • Dollar amount of the requested supplement
    • Name and title of the authorized institutional official who has signed the cover supplement request, and
    • Phone, email, and address information for both the PD/PI and the institutional official.
  2. PHS 398 Form Page 1 (Face page) MS Word  PDF 

    • The title of the project (Box 1) should be the title of the parent award.
    • The Project Director/Principal Investigator (PD/PI) must be the same as the PD/PI on the parent award. For Multiple PD/PI parent awards, the Contact PD/PI must be the PD/PI listed on the supplement request. Administrative supplements cannot change the Multiple PD/PI team or convert a grant from a single PD/PI to a multiple PD/PI grant.
    • The remaining items on the face page should be filled out in accordance with the PHS 398 application instructions.
  3. PHS 398 Form page 2 MS Word  PDF  Note: The project “summary” is that of the administrative supplement, not the parent grant. All other information requested on Form Page 2 should be provided.

  4. A brief proposal describing the project, including:

    • Scope of the overall project and the anticipated contribution of the requested supplement (not to exceed five pages). This section should include a description of the supplement's purpose; including research design/proposed scientific activities and methods and data analysis. Describe the relationship of the supplement request to the parent grant. Specifically, summarize how the activities proposed in the supplemental request fit within the scope/aims of the parent grant. Identify and clearly state how the supplement request fits within one or more of the three solicited topics identified above as areas of interest for NIMH.
    • Budget for the supplement with a justification that details the items requested, including F&A costs and a justification for all personnel and their role(s) in this project. Note the budget should be appropriate for the work proposed in the supplement request. Applicants are encouraged to discuss budgets with their NIH Program Officer. All supplement requests must include detailed budgets on the PHS 398 Form Pages 4 (MS Word  PDF ) and 5 (MS Word  PDF ). Modular budget pages will not be accepted even when the parent grant was funded as a modular grant. See Budget and Funding Information  below for additional information.
    • Biographical Sketch for all new Senior/Key Personnel. There is no need to repeat information previously provided for other Senior/Key Personnel. MS Word  PDF 
    • Human Subjects/Vertebrate Animal documentation (if applicable). Include a current Human Subjects/Institutional Review Board (IRB) or Vertebrate Animals/Institutional Animal Care and Use Committee (IACUC) approval letter, if applicable. Otherwise, this letter will be required at time of funding. All appropriate IRB and IACUC approvals must be in place prior to a supplement award being made.
  5. PHS 398 Checklist Form MS Word  PDF 


NIMH will allocate approximately $10 million for administrative supplements in FY2010. Generally requests are expected to be no more that 25% of the total costs of the parent grant (includes F&A). Individual supplement requests cannot to exceed $2 million in total costs (includes F&A).

For requests submitted in response to the topic area of sharing autism spectrum disorder data via the National Database for Autism Research, please use the cost and effort model tool referenced above when developing the budget.

Applications should request a start date no sooner than June 1, 2010.

Application Receipt Dates for All Recovery Act Administrative Supplements is March 5, 2010.

Please submit all applications for Administrative Supplements electronically via the following link: 

  • The PI of the parent grant is required to submit the supplement request via the web link above.
  • When the PI clicks on the link, the PI will be asked to provide his/her eRA Commons ID and password.
  • Once on the submission page, please select ARRA Administrative Supplement when prompted for the type of supplement.
  • Follow the instructions on the webpage to upload the administrative supplement application packet.
  • The PI will receive an e-mail confirmation and a supplement request number when the supplement is successfully submitted. This information will also appear on the screen when the submission has been successfully received by NIMH. Please retain this information as this will be a means to identify your request when contacting NIMH.
  • Do NOT submit the same supplement more than once, even if a correction is required. If there is an error, please contact Tracy Waldeck at to withdraw your previous submission BEFORE submitting the corrected application.

For specific questions regarding eligibility or questions about the science to be proposed, the PI should contact the NIMH Program Official for the parent grant.

For general information on NIMH’s Recovery Act Supplements or questions on how to submit contact:

Tracy Waldeck, Ph.D.
Associate Director for Special Projects
National Institute of Mental Health
National Institutes of Health
Phone: (301) 435-0322

For financial or grants management questions contact:

Rebecca Claycamp, M.S., CRA
Chief Grants Management Officer
National Institute of Mental Health
6001 Executive Boulevard, Room 6115, MSC 9605
Bethesda, MD 20892-9605
Telephone: 301-402-7111

Return to the NIMH Supplements Homepage